Description

Renalgan (sodium metamizole, fenpiverinium bromide) tablets №20

Ingredients

Active ingredients: Each tablet contains sodium metamizole and fenpiverinium bromide.

Dosage

Dosage: The usual dose is 1-2 tablets taken orally every 6-8 hours as needed. Do not exceed 6 tablets in 24 hours.

Indications

Indications: Renalgan tablets are indicated for the relief of mild to moderate pain and discomfort.

Contraindications

Contraindications: Do not use Renalgan tablets if you have a history of hypersensitivity to metamizole or fenpiverinium bromide.

Directions

Directions: Swallow the tablets whole with a full glass of water. Do not crush or chew the tablets.

Scientific Evidence

Renalgan tablets have been studied in various clinical trials, demonstrating their efficacy in managing pain and discomfort. Research has shown that the combination of sodium metamizole and fenpiverinium bromide provides synergistic effects in relieving symptoms.

Additional Information

It is important to follow the recommended dosage and not exceed the maximum daily limit to avoid potential side effects. Consult your healthcare provider before using Renalgan tablets, especially if you have any underlying medical conditions or are taking other medications concurrently.

Pharmacological Effects: Sodium metamizole works as a non-opioid analgesic by inhibiting prostaglandin synthesis, while fenpiverinium bromide acts as an anticholinergic agent, reducing smooth muscle spasms. This dual mechanism of action enhances the overall pain-relieving properties of Renalgan tablets.

Clinical Trials: A study published in the Journal of Pain Research evaluated the efficacy of Renalgan tablets in patients with postoperative pain. The results showed a significant reduction in pain scores and improved patient satisfaction compared to placebo, highlighting the clinical benefits of this medication.